Finance

Lists
Why is 300683 down 2,94%?
Dive Deeper
300683:SHE
Wuhan Hiteck Biological Pharma Co Ltd
23,80 CN¥
-2,94%
(-0,72) 1D
16 հոկ, 15:04:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300683...
Open
24,86 CN¥
High
25,68 CN¥
Low
23,62 CN¥
Mkt. cap
3,12 մլրդ
Avg. vol.
6,29 մլն
Volume
9,01 մլն
52-wk high
50,68 CN¥
52-wk low
22,37 CN¥
EPS
-2,07 CN¥
Shares outstanding
130,89 մլն
No. of employees
958
Open
24,86 CN¥
High
25,68 CN¥
Low
23,62 CN¥
Mkt. cap
3,12 մլրդ
Avg. vol.
6,29 մլն
Volume
9,01 մլն
52-wk high
50,68 CN¥
52-wk low
22,37 CN¥
EPS
-2,07 CN¥
Shares outstanding
130,89 մլն
No. of employees
958
News stories
From web sources and news partners
About Wuhan Hiteck Biological Pharma Co Ltd
CEO-
Employees958
Founded08 ապր, 1992 թ.
Headquarters-
Sector-
Websitehiteck.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
146,84 մլն
119,55 մլն
159,05 մլն
66,47 մլն
Cost of goods sold
79,88 մլն
78,74 մլն
97,87 մլն
53,09 մլն
Cost of revenue
79,88 մլն
78,74 մլն
97,87 մլն
53,09 մլն
Research and development expenses
19,60 մլն
21,91 մլն
19,43 մլն
19,95 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75,67 մլն
72,55 մլն
60,07 մլն
56,77 մլն
Operating expense
83,83 մլն
115,96 մլն
77,22 մլն
84,95 մլն
Total operating expenses
163,70 մլն
194,71 մլն
175,09 մլն
138,04 մլն
Operating income
-16,87 մլն
-75,16 մլն
-16,05 մլն
-71,57 մլն
Other non operating income
-3,02 մլն
3,36 մլն
-103,60 հզր
114,73 հզր
EBT including unusual items
-127,52 մլն
-66,89 մլն
-26,83 մլն
-60,40 մլն
EBT excluding unusual items
-18,53 մլն
-62,83 մլն
-15,50 մլն
-70,17 մլն
Income tax expense
-6,84 մլն
7,65 մլն
-2,90 մլն
-4,44 մլն
Effective tax rate
5,36%
-11,44%
10,81%
7,35%
Other operating expenses
-6,81 մլն
10,42 մլն
-904,39 հզր
4,52 մլն
Net income
-118,91 մլն
-73,17 մլն
-23,05 մլն
-55,66 մլն
Net profit margin
-80,98%
-61,21%
-14,49%
-83,74%
Earnings per share
-
-
-
-
Interest and investment income
1,71 մլն
9,29 մլն
920,58 հզր
1,56 մլն
Interest expense
-322,55 հզր
-319,50 հզր
-266,56 հզր
-258,59 հզր
Net interest expenses
1,39 մլն
8,97 մլն
654,02 հզր
1,30 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
4,85 մլն
-51,87 մլն
7,24 մլն
-49,78 մլն
Gain or loss from assets sale
-572,00
979,18 հզր
-
2,30 մլն
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps